{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:06:01Z","timestamp":1790553961885,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,3,14]],"date-time":"2013-03-14T00:00:00Z","timestamp":1363219200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"DOI":"10.1038\/cddis.2013.73","type":"journal-article","created":{"date-parts":[[2013,3,14]],"date-time":"2013-03-14T15:23:09Z","timestamp":1363274589000},"page":"e545-e545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":191,"title":["Influence of microRNA deregulation on chaperone-mediated autophagy and \u03b1-synuclein pathology in Parkinson's disease"],"prefix":"10.1038","volume":"4","author":[{"given":"L","family":"Alvarez-Erviti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Seow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A HV","family":"Schapira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M C","family":"Rodriguez-Oroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Obeso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,14]]},"reference":[{"key":"BFcddis201373_CR1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M . Alpha-synuclein in Lewy bodies. Nature 1997; 388: 839\u2013840.","journal-title":"Nature"},{"key":"BFcddis201373_CR2","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A et al. Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 1997; 276: 2045\u20132047.","journal-title":"Science"},{"key":"BFcddis201373_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J et al. Alpha-synuclein locus triplication causes Parkinson\u2019s disease. Science 2003; 302: 841.","journal-title":"Science"},{"key":"BFcddis201373_CR4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0140-6736(10)62345-8","volume":"377","author":"MA Nalls","year":"2011","unstructured":"Nalls MA, Plagnol V, Hernandez DG, Sharma M, Sheerin UM, Saad M et al. Imputation of sequence variants for identification of genetic risk for Parkinson\u2019s disease: a meta-analysis of genome wide association studies. Lancet 2011; 377: 641\u2013649.","journal-title":"Lancet"},{"key":"BFcddis201373_CR5","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1126\/science.1101738","volume":"305","author":"AM Cuervo","year":"2004","unstructured":"Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D . Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 2004; 305: 1292\u20131295.","journal-title":"Science"},{"key":"BFcddis201373_CR6","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1001\/archneurol.2010.198","volume":"67","author":"L Alvarez-Erviti","year":"2010","unstructured":"Alvarez-Erviti L, Rodriguez-Oroz MC, Cooper JM, Caballero C, Ferrer I, Obeso JA et al. Chaperone-mediated autophagy markers in Parkinson disease brains. Arch Neurol 2010; 67: 1464\u20131472.","journal-title":"Arch Neurol"},{"key":"BFcddis201373_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0968-0004(90)90019-8","volume":"15","author":"JF Dice","year":"1990","unstructured":"Dice JF . Peptide sequences that target cytosolic proteins for lysosomal proteolysis. Trends Biochem Sci 1990; 15: 305\u2013309.","journal-title":"Trends Biochem Sci"},{"key":"BFcddis201373_CR8","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1016\/j.biocel.2004.02.013","volume":"36","author":"AE Majeski","year":"2004","unstructured":"Majeski AE, Dice JF . Mechanisms of chaperone-mediated autophagy. Int J Biochem Cell Biol 2004; 36: 2435\u20132444.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFcddis201373_CR9","doi-asserted-by":"publisher","first-page":"23542","DOI":"10.1074\/jbc.M801992200","volume":"283","author":"T Vogiatzi","year":"2008","unstructured":"Vogiatzi T, Xilouri M, Vekrellis K, Stefanis L . Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem 2008; 283: 23542\u201323556.","journal-title":"J Biol Chem"},{"key":"BFcddis201373_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis BP, Burge CB, Bartel DP . Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15\u201320.","journal-title":"Cell"},{"key":"BFcddis201373_CR11","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1126\/science.1073827","volume":"297","author":"G Hutv\u00e1gner","year":"2002","unstructured":"Hutv\u00e1gner G, Zamore PD . A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002; 297: 2056\u20132060.","journal-title":"Science"},{"key":"BFcddis201373_CR12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nm1569","volume":"13","author":"B Yang","year":"2007","unstructured":"Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007; 13: 486\u2013491.","journal-title":"Nat Med"},{"key":"BFcddis201373_CR13","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1140481","volume":"317","author":"J Kim","year":"2007","unstructured":"Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E et al. microRNA feedback circuit in midbrain dopamine neurons. Science 2007; 317: 1220\u20131224.","journal-title":"Science"},{"key":"BFcddis201373_CR14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1023\/B:NERE.0000014826.00881.c3","volume":"29","author":"JL Bradley","year":"2004","unstructured":"Bradley JL, Homayoun S, Hart PE, Schapira AH, Cooper JM . Role of oxidative damage in Friedreich\u2019s ataxia. Neurochem Res 2004; 29: 561\u2013567.","journal-title":"Neurochem Res"},{"key":"BFcddis201373_CR15","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1046\/j.1471-4159.1994.63051987.x","volume":"63","author":"A Hartley","year":"1994","unstructured":"Hartley A, Stone JM, Heron C, Cooper JM, Schapira AH . Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson\u2019s disease. J Neurochem 1994; 63: 1987\u20131990.","journal-title":"J Neurochem"},{"key":"BFcddis201373_CR16","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1006\/bbrc.1995.2528","volume":"215","author":"DS Konecki","year":"1995","unstructured":"Konecki DS, Foetisch K, Zimmer KP, Schlotter M, Lichter-Konecki U . An alternatively spliced form of the human lysosome-associated membrane protein-2 gene is expressed in a tissue-specific manner. Biochem Biophys Res Commun 1995; 215: 757\u2013767.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcddis201373_CR17","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1083\/jcb.137.5.1161","volume":"137","author":"NR Gough","year":"1997","unstructured":"Gough NR, Fambrough DM . Different steady state subcellular distributions of the three splice variants of lysosome-associated membrane protein LAMP-2 are determined largely by the COOH-terminal amino acid residue. J Cell Biol 1997; 137: 1161\u20131169.","journal-title":"J Cell Biol"},{"key":"BFcddis201373_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/1531-8257(199905)14:3<417::AID-MDS1005>3.0.CO;2-X","volume":"14","author":"M Neystat","year":"1999","unstructured":"Neystat M, Lynch T, Przedborski S, Kholodilov N, Rzhetskaya M, Burke RE . Alpha-synuclein expression in substantia nigra and cortex in Parkinson\u2019s disease. Mov Disord 1999; 14: 417\u2013422.","journal-title":"Mov Disord"},{"key":"BFcddis201373_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/mds.10683","volume":"19","author":"AE Kingsbury","year":"2004","unstructured":"Kingsbury AE, Daniel SE, Sangha H, Eisen S, Lees AJ, Foster OJ . Alteration in alpha-synuclein mRNA expression in Parkinson\u2019s disease. Mov Disord 2004; 19: 162\u2013170.","journal-title":"Mov Disord"},{"key":"BFcddis201373_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/brain\/awp282","volume":"133","author":"J Tong","year":"2010","unstructured":"Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M et al. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson\u2019s disease and progressive supranuclear palsy: a comparative investigation. Brain 2010; 133: 172\u2013188.","journal-title":"Brain"},{"key":"BFcddis201373_CR21","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/j.1471-4159.2009.06191.x","volume":"110","author":"KY Chau","year":"2009","unstructured":"Chau KY, Ching HL, Schapira AH, Cooper JM . Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson\u2019s disease pathogenesis. J Neurochem 2009; 110: 1005\u20131013.","journal-title":"J Neurochem"},{"key":"BFcddis201373_CR22","first-page":"777","volume":"118","author":"M Martinez-Vicente","year":"2008","unstructured":"Martinez-Vicente M, Talloczy Z, Kaushik S, Massey AC, Mazzulli J, Mosharov EV et al. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J Clin Invest 2008; 118: 777\u2013788.","journal-title":"J Clin Invest"},{"key":"BFcddis201373_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev-pathol-011110-130242","volume":"6","author":"JM Shulman","year":"2011","unstructured":"Shulman JM, De Jager PF, Feany MB . Parkinson\u2019s disease: genetics and pathogenesis. Annu Rev Pathol Mech Dis 2011; 6: 193\u2013222.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"BFcddis201373_CR24","doi-asserted-by":"publisher","first-page":"7006","DOI":"10.1523\/JNEUROSCI.22-16-07006.2002","volume":"22","author":"TB Sherer","year":"2002","unstructured":"Sherer TB, Betarbet R, Stout AK, Lund S, Baptista M, Panov AV et al. An in vitro model of Parkinson\u2019s disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. J Neurosci 2002; 22: 7006\u20137015.","journal-title":"J Neurosci"},{"key":"BFcddis201373_CR25","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1074\/jbc.C100560200","volume":"277","author":"AB Manning-Bog","year":"2002","unstructured":"Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA . The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem 2002; 277: 1641\u20131644.","journal-title":"J Biol Chem"},{"key":"BFcddis201373_CR26","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1046\/j.1471-4159.2003.02152.x","volume":"88","author":"E Biasini","year":"2004","unstructured":"Biasini E, Fioriti L, Ceglia I, Invernizzi R, Bertoli A, Chiesa R et al. Proteasome inhibition and aggregation in Parkinson\u2019s disease: a comparative study in untransfected and transfected cells. J Neurochem 2004; 88: 545\u2013553.","journal-title":"J Neurochem"},{"key":"BFcddis201373_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","volume":"9","author":"N Yanaihara","year":"2006","unstructured":"Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9: 189\u2013198.","journal-title":"Cancer Cell"},{"key":"BFcddis201373_CR28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/ng.317","volume":"41","author":"SA Melo","year":"2009","unstructured":"Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, Calin GA et al. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 2009; 41: 365\u2013370.","journal-title":"Nat Genet"},{"key":"BFcddis201373_CR29","doi-asserted-by":"publisher","first-page":"6415","DOI":"10.1073\/pnas.0710263105","volume":"105","author":"SS H\u00e9bert","year":"2008","unstructured":"H\u00e9bert SS, Horr\u00e9 K, Nicola\u00ef L, H\u00e9bert SS, Horr\u00e9 K, Nicola\u00ef L et al. Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer\u2019s disease correlates with increased BACE1\/beta-secretase expression. Proc Natl Acad Sci USA 2008; 105: 6415\u20136420.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis201373_CR30","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/nn.2183","volume":"11","author":"Y Lee","year":"2008","unstructured":"Lee Y, Samaco RC, Gatchel JR, Thaller C, Orr HT, Zoghbi HY . miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nat Neurosci 2008; 11: 1137\u20131139.","journal-title":"Nat Neurosci"},{"key":"BFcddis201373_CR31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nrg3162","volume":"13","author":"AE Pasquinelli","year":"2012","unstructured":"Pasquinelli AE . MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev 2012; 13: 271\u2013282.","journal-title":"Nat Rev"},{"key":"BFcddis201373_CR32","doi-asserted-by":"publisher","first-page":"13052","DOI":"10.1073\/pnas.0906277106","volume":"1060","author":"E Junn","year":"2009","unstructured":"Junn E, Lee KW, Jeong BS, Chan TW, Im JY, Mouradian MM . Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc Natl Acad Sci USA 2009; 1060: 13052\u201313057.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis201373_CR33","doi-asserted-by":"publisher","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","volume":"285","author":"E Doxakis","year":"2010","unstructured":"Doxakis E . Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J Biol Chem 2010; 285: 12726\u201312734.","journal-title":"J Biol Chem"},{"key":"BFcddis201373_CR34","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nature09191","volume":"466","author":"S Gehrke","year":"2010","unstructured":"Gehrke S, Imai Y, Sokol N, Lu B . Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 2010; 466: 637\u2013641.","journal-title":"Nature"},{"key":"BFcddis201373_CR35","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/mt.2008.82","volume":"16","author":"A Ely","year":"2008","unstructured":"Ely A, Naidoo T, Mufamadi S, Crowther C, Arbuthnot P . Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo. Mol Ther 2008; 16: 1105\u20131112.","journal-title":"Mol Ther"},{"key":"BFcddis201373_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2199-7-3","volume":"7","author":"A Schroeder","year":"2006","unstructured":"Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 2006; 7: 3.","journal-title":"BMC Mol Biol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cddis201373.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cddis201373","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis201373.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:01:25Z","timestamp":1672963285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis201373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,14]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3]]}},"alternative-id":["BFcddis201373"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2013.73","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,14]]},"assertion":[{"value":"31 August 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. JA Obeso has served on the Advisory Board of TEVA Pharmaceutica in the past 3 years and once for TEVA Neuroscience (USA) in 2012 and has received honorarium for lecturing in meetings organized by GSK, Lundbeck-TEVA and UCB in Spain. He was funded by the Spanish Science and Education Ministry and European Union (REPLACES). Maria C Rodriguez-Oroz has received payment for lectures, as well as travel and accommodation to attend scientific meetings, from UCB and Lundbeck. She has received research funding from national and regional government bodies in Spain. Professor Schapira and Drs. Alvarez-Erviti, Seow and Cooper declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}